rilonacept 160 mg

DRUG2 trials

Sponsors

Regeneron Pharmaceuticals

Conditions

Familial Cold Autoinflammatory Syndrome (FCAS)Familial Cold UrticariaGenetic Diseases, InbornIntercritical GoutMuckle-Wells Syndrome (MWS)

Phase 3

Rilonacept for Treatment of Cryopyrin-Associated Periodic Syndromes (CAPS)

CompletedNCT00288704

Regeneron PharmaceuticalsFamilial Cold Autoinflammatory Syndrome (FCAS), Familial Cold Urticaria, Genetic Diseases, Inborn +1

Start: 2005-12-31End: 2008-08-31Updated: 2011-12-06

PREventative Study Against URate-lowering Drug-induced Gout Exacerbations 1

CompletedNCT00829829

Regeneron PharmaceuticalsIntercritical Gout

Start: 2009-02-28End: 2010-06-30Updated: 2017-04-28